Phase 2/3 study of CEM-102 for the treatment of acute bacterial skin structure infections (ABSSI)
Monday, September 14th, 2009
Cempra Pharmaceuticals announced…read more
You are browsing:
Home » News & Events » Article: Phase 2/3 study of CEM-102 for the treatment of acute bacterial skin structure infections (ABSSI)
- News Room
Archives by Month:
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- November 2007
- October 2007
- September 2007
- August 2007
- July 2007
- May 2006
- February 2006
Careers by location
Latest Careers
- June 10, 2010
- Software Test Engineer
- Located in: Abingdon, Careers
- Management Accountant
- Located in: Abingdon, Careers
- April 1, 2010
- Graduate Software Engineer
- Located in: Abingdon, Boston (USA), Burton, Careers, Den Haag (NL), Stevenage, Warrington, Washington DC (USA)
- Performance Improvement Consultant – Life Sciences
- Located in: Abingdon, Burton, Careers, Stevenage, Warrington
